BIOMARKERS TO DETECT CENTRAL DOPAMINE DEFICIENCY AND DISTINGUISH PARKINSON DISEASE FROM MULTIPLE SYSTEM ATROPHY

OBJECTIVE: Biomarkers are increasingly important to diagnose and test treatments of neurodegenerative diseases such as Parkinson disease (PD). This study compared neuroimaging, neurochemical, and olfactory potential biomarkers to detect central dopamine (DA) deficiency and distinguish PD from multip...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Goldstein, David S., Holmes, Courtney, Bentho, Oladi, Sato, Takuya, Moak, Jeffrey, Sharabi, Yehonatan, Imrich, Richard, Conant, Shielah, Eldadah, Basil A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2650101/
https://ncbi.nlm.nih.gov/pubmed/18325818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2008.01.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky